Hospital.Help

Berlin – Experts largely view the European Medicines Agency’s (EMA) recommendation for lecanemab, announced yesterday, as positive, but point out that it is only an option for a small number of people with mild cognitive impairment (MCI) or early dementia . “Lecanemab is not a miracle cure, but it intervenes for the first time in one of the pathomechanisms of Alzheimer’s,” said Peter Berlit, Secretary General of…